TrianglePUBLICATIONS · 30787022
FDA Approval Summary: Pembrolizumab for the Treatment of Microsatellite Instability-High Solid Tumors.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Clin Cancer Res
- Publication date
- 2019 Jul 1
- First author
- Marcus L
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Marcus L
- type
- Author
- name
- Lemery SJ
- type
- Author
- name
- Keegan P
- type
- Author
- name
- Pazdur R
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Marcus L
- type
- Author
- name
- Lemery SJ
- type
- Author
- name
- Keegan P
- type
- Author
- name
- Pazdur R
- type
- Author
- bibliography ids
- nci-bib-8cfb653516f8a45e46f1ac57
- book metadata
- content sha256
- ab08715ea320bf124f8c32223fd526a1ea86691e387243ca6679e086567aa954
- document type
- citation
- dois
- 10.1158/1078-0432.CCR-18-4070
- electronic publication date
- display
- 2019 Feb 20
- precision
- day
- year
- 2019
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:30787022
- immutable id
- pubmed:30787022@ab08715ea320bf124f8c32223fd526a1ea86691e387243ca6679e086567aa954
- journal
- abbreviation
- Clin Cancer Res
- issn electronic
- 1557-3265
- issn print
- 1078-0432
- issue
- 13
- name
- Clinical cancer research : an official journal of the American Association for Cancer Research
- nlm unique id
- 9502500
- pages
- 3753-3758
- volume
- 25
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 30787022
- provenance
- batch id
- e808962322f3afebc564
- provider
- NCBI PubMed ESummary
- record sha256
- 34e9056cdeb2124cd7496ecf84f7ece343be9a30d844e6898b9d05a44d9fbbb8
- response sha256
- 3d610336ca8dae92b82cdb6b3ee6cab382eb509e0349b0c68c261b042b036561
- retrieved at
- 2026-09-09T23:47:41.002093+00:00
- publication date
- display
- 2019 Jul 1
- precision
- day
- year
- 2019
- publication types
- Journal Article
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- FDA Approval Summary: Pembrolizumab for the Treatment of Microsatellite Instability-High Solid Tumors.
Preserved source evidence · Independent clinical review pending · Not medical advice